Pine Haven Investment Counsel Inc Boosts Stock Position in Oracle Corporation $ORCL

Pine Haven Investment Counsel Inc boosted its stake in Oracle Corporation (NYSE:ORCL) by 0.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,920 shares of the enterprise software provider’s stock after acquiring an additional 110 shares during the period. Oracle accounts for 2.0% of Pine Haven Investment Counsel Inc’s portfolio, making the stock its 11th largest position. Pine Haven Investment Counsel Inc’s holdings in Oracle were worth $2,606,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also bought and sold shares of ORCL. Redmont Wealth Advisors LLC bought a new position in Oracle during the 1st quarter worth approximately $27,000. Inlight Wealth Management LLC acquired a new stake in shares of Oracle during the 1st quarter valued at approximately $28,000. Iron Horse Wealth Management LLC lifted its stake in Oracle by 284.9% during the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider’s stock worth $29,000 after purchasing an additional 151 shares during the last quarter. Graybill Wealth Management LTD. acquired a new position in Oracle in the first quarter worth $39,000. Finally, Operose Advisors LLC increased its stake in Oracle by 50.2% during the first quarter. Operose Advisors LLC now owns 314 shares of the enterprise software provider’s stock valued at $44,000 after purchasing an additional 105 shares during the last quarter. 42.44% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently issued reports on ORCL. Jefferies Financial Group raised their price target on shares of Oracle from $270.00 to $360.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Westpark Capital upped their target price on Oracle from $195.00 to $246.00 and gave the company a “buy” rating in a report on Thursday, June 12th. Cantor Fitzgerald raised their price target on Oracle from $271.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, September 10th. Stifel Nicolaus upped their price objective on Oracle from $250.00 to $350.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Finally, Evercore ISI raised their target price on Oracle from $270.00 to $340.00 and gave the company an “outperform” rating in a research note on Wednesday, September 10th. Two analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, Oracle currently has an average rating of “Moderate Buy” and an average target price of $305.75.

Insider Buying and Selling at Oracle

In other news, insider Clayton M. Magouyrk sold 21,241 shares of the company’s stock in a transaction on Friday, September 12th. The stock was sold at an average price of $297.11, for a total value of $6,310,913.51. Following the completion of the sale, the insider owned 78,000 shares in the company, valued at $23,174,580. This represents a 21.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Michael D. Sicilia sold 33,845 shares of Oracle stock in a transaction dated Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total value of $10,869,660.20. Following the transaction, the insider directly owned 132,656 shares in the company, valued at approximately $42,603,800.96. The trade was a 20.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 112,092 shares of company stock valued at $32,960,165. 42.20% of the stock is currently owned by company insiders.

Oracle Trading Down 4.0%

Shares of ORCL stock opened at $314.90 on Wednesday. Oracle Corporation has a 1 year low of $118.86 and a 1 year high of $345.72. The firm has a market capitalization of $894.84 billion, a PE ratio of 72.89, a price-to-earnings-growth ratio of 3.55 and a beta of 1.46. The stock has a fifty day moving average of $255.23 and a two-hundred day moving average of $197.74. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. Oracle’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, research analysts expect that Oracle Corporation will post 5 EPS for the current year.

Oracle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be issued a $0.50 dividend. The ex-dividend date is Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.6%. Oracle’s dividend payout ratio (DPR) is 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.